Akut mieloid leukémia (AML): vizsgálatok itt: Románia
10 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleMocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
- Where
- Bucharest, Iași
- Életkor
- 18 év to 75 év
- People
- 366 worldwide
- Run by
- Priothera SAS
See details and how to joinNCT05429632 - 3. fázisTaking peoplePivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Where
- Cluj-Napoca
- Életkor
- 18 év to 71 év
- People
- 150 worldwide
- Run by
- Quetzal Therapeutics
See details and how to joinNCT07504458 · EU 2025-524810-28-00 - No phaseTaking peopleMaster Framework For Relapse or Refractory Acute Myeloid Leukemia
- Where
- Bucharest
- Életkor
- 6 év and over
- People
- 4000 worldwide
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06459024 - 3. fázisTaking peopleIMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
- Where
- Bucharest
- Életkor
- 18 év and over
- People
- 339 worldwide
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06713837 · EU 2024-514517-35-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Bucharest, Cluj-Napoca, Iași, Târgu Mureş, Timisoara
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 2/3. fázisTaking peopleL-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
- Where
- Bucharest, Cluj-Napoca, Craiova, Timisoara
- Életkor
- 18 év to 80 év
- People
- 312 worldwide
- Run by
- Moleculin Biotech, Inc.
See details and how to joinNCT06788756 · EU 2024-518359-47-00 - 2. fázisCsak meghívásosA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Bucharest, Cluj-Napoca
- Életkor
- 18 év and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01 - 1. fázisTaking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Where
- Bucharest, Cluj-Napoca
- Életkor
- 18 év and over
- People
- 18 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953897 · EU 2024-516291-16-00 - 1. fázisTaking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Where
- Bucharest, Cluj-Napoca
- Életkor
- 18 év and over
- People
- 27 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953910 · EU 2024-516292-33-00 - 3. fázisTaking peopleAn Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
- Where
- Bucharest, Cluj-Napoca
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- Servier Affaires Médicales
See details and how to joinNCT05907057 · EU 2022-501709-11-00